Toxocariasis in the Americas: Burden and Disease Control
- Adrián Bolivar-Mejia,
- Camila Alarcón-Olave,
- Lauren S. Calvo-Betancourt,
- Alberto Paniz-Mondolfi,
- Olinda Delgado,
- Universidad Industrial de Santander,
- Instituto de Biomedicina,
- St. Luke’s-Roosevelt Hospital Center,
- UCV,
- Universidad Tecnológica de Pereira,
- International Society for Chemotherapy (ISC) Working Group on Zoonoses Committee
Research Output:
Contribution to journal
Review article
Peer-reviewOpen access
Publication Information
Output type
Research Output:
Contribution to journal
Review article
Peer-reviewOriginal language
EnglishPages from-to (Number of pages)
Pages 62-68 (7 pages)Journal (Volume, Issue Number)
Current Tropical Medicine Reports (Volume 1, Issue 1)Publication milestones
- Published - 01/03/2014
Publication status
Published - 01/03/2014
Publication IDs
- Scopus: 84929362024
Abstract
Human toxocariasis is a zoonotic parasitic disease that represents extensive morbidity in many countries. Caused by Toxocara canis and Toxocara cati, the clinical spectrum of this helminthiasis can be extended from asymptomatic forms up to life-threatening syndromes, such as the visceral larva migrans. Its epidemiology and burden is not clear; many times it is not diagnosed and, in most countries, it is not a notifiable disease. Some recent reviews have shown a large range of variability in terms of reported seroprevalence by countries. In this review, we summarized information regarding human toxocariasis burden of disease and control efforts in the region of the Americas.
Access to documents
Publication metrics
Metrics
Sustainable Development Goals
- SDG 3 Good Health and Well
